Search

Sitting Down With... Ron Heeren, Director of Maastricht MultiModal Molecular Imaging Institute

A drug used to treat MS could be repurposed to treat infections in cystic fibrosis patients

Sometimes, medical innovation may need to go backwards to go forwards

For inhaler technology to evolve, questions about efficacy must be answered

Precision medicine often relies on population databases – but are they precise enough?

Lack of faith in the healthcare system could be causing non-adherence in cancer patients

Creating a ceramic “window” in the skull could provide better access to the brain

Mutations in four main genes influence survival rates of pancreatic adenocarcinoma patients

As molecular diagnostic methods evolve, so does our approach to microbial testing…

Rodent models are a useful tool for studying the microbiome – but we need to know their limits